Value of Dual-Energy Computed Tomography for Diagnosing Cervical Lymph Node Metastasis in Patients With Papillary Thyroid Cancer
Authors:
- 1 November 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 43 (6) , 970-975
Abstract
Objective: The objective of this study was to determine the value of dual-energy computed tomography (DECT) for the diagnosis of cervical lymph node metastasis in papillary thyroid cancer. Methods: The normalized iodine concentration (NIC) and the slope of the spectral Hounsfield unit curve (λ HU) in the arterial and venous phases were measured using iodine-overlay images and spectral curves. Quantitative DECT data and qualitative conventional CT data were analyzed by radiologists. Results: The best qualitative parameter for lymph node metastasis detection was obvious node enhancement, and the best quantitative parameter for detection was arterial-phase NIC, which showed high sensitivity, specificity, and accuracy values at an optimal threshold of 25.8%. The best combination of qualitative and quantitative parameters consisted of obvious enhancement and arterial-phase NIC; this combination showed a sensitivity of 90.8% and a specificity of 80.5%. Conclusions: The DECT quantitative parameters NIC and λ HU can be an additional tool to diagnose cervical lymph node metastasis.Keywords
This publication has 24 references indexed in Scilit:
- Dual-Energy CT Applications in Head and Neck ImagingAmerican Journal of Roentgenology, 2012
- The Most Commonly Occurring Papillary Thyroid Cancer in the United States Is Now a Microcarcinoma in a Patient Older than 45 YearsThyroid®, 2011
- Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancerThe Laryngoscope, 2010
- Diagnosis of lymph node metastases of head and neck cancer and evaluation of effects of chemoradiotherapy using ultrasonographyInternational Journal of Clinical Oncology, 2010
- Advances in Ultrasound for the Diagnosis and Management of Thyroid CancerThyroid®, 2009
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- Phase II Trial of Sorafenib in Metastatic Thyroid CancerJournal of Clinical Oncology, 2009
- Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinomaJournal of Surgical Oncology, 2008
- US-Elastography in the Differential Diagnosis of Benign and Malignant Thyroid NodulesThyroid®, 2008
- Preoperative Diagnosis of Cervical Metastatic Lymph Nodes in Papillary Thyroid Carcinoma: Comparison of Ultrasound, Computed Tomography, and Combined Ultrasound with Computed TomographyThyroid®, 2008